Anthracyline
Brand names,
Anthracyline
Analogs
Anthracyline
Brand Names Mixture
Anthracyline
Chemical_Formula
C27H29NO10
Anthracyline
RX_link
http://www.rxlist.com/cgi/generic2/daunorubicin.htm
Anthracyline
fda sheet
Anthracyline
msds (material safety sheet)
Anthracyline
Synthesis Reference
J. P. Parsh et al. J. Pharm. Sci. 56, 1691 (1967);
Anthracyline
Molecular Weight
527.52 g/mol
Anthracyline
Melting Point
208-209 oC
Anthracyline
H2O Solubility
39.2 mg/L
Anthracyline
State
Solid
Anthracyline
LogP
0.766
Anthracyline
Dosage Forms
Powder for solution; Suspension
Anthracyline
Indication
For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.
Anthracyline
Pharmacology
Daunorubicin is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Daunorubicin may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Daunorubicin possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.
Anthracyline
Absorption
No information avaliable
Anthracyline
side effects and Toxicity
LD50=20 mg/kg (mice, IV); LD50=13 mg/kg (rat, IV)
Anthracyline
Patient Information
Anthracyline
Organisms Affected
Humans and other mammals